Vaccination News Home Page

http://news.bmn.com/news/story?day=021107&story=1

 
Research
Tools
Reviews Journal
Collection
News &
Comment
Books &
Labware
Science
Jobs
Web
Links
news.bmn.com Latest
Updates
Today's
News
Magazine Conference
Reporter
Commentary Journal
Scan
Special
Report
My E-mail
Alerts
Section
Search
  My BMN My BMN Exit Exit  
  Send Feedback to BMN Feedback Help System Help  


 

Today's News
 Front Page
 News Archive
 Send us News Tips


 

Quick Site Search

 

Advanced site search


 

 


 

- 7 November 2002
Today's News Stories
News Archive
     
Research standards to prevent bioterrorism are in the works

6 November 2002 19:00 GMT

by Bea Perks

researcher in protective garmentsThe Royal Society has today submitted a proposal to the British Government in support of an international code of conduct governing research vulnerable to bioterrorist exploitation. The aims are laudable, says leading US microbiologist John Collier, but achieving them presents a serious challenge.

The proposal was submitted to the government's Foreign and Commonwealth Office (FCO) in preparation for a forthcoming meeting of signatories to the 1972 Biological and Toxic Weapons Convention (BTWC) in Geneva next week. The FCO will represent Britain's interests at the meeting. (A parallel document is expected in the US within a few months.)

In a six-page document, members of the Royal Society's standing committee on the Scientific Aspects of International Security discuss the growing threat of biological warfare facing the international community.

The committee concludes by supporting the creation of an International Advisory Panel together with a universally agreed set of standards on which to base a much longer-term project - the creation of an international code of conduct. "Serious consideration needs to be given as to how to ensure that such a code will be effective," warn committee members. "This includes questions such as how the code and good practice procedures will be enforced, who will be responsible for checking a researcher's work, [and] what penalties would occur if a researcher contravened the code."

The creation of such a code would require very serious consideration indeed, says Collier, professor of microbiology and molecular genetics in the department of microbiology and molecular genetics at Harvard Medical School. Collier is on the National Academies of Science (NAS) committee on Research Standards and Practices to Prevent Destructive Application of Advanced Biotechnology - the US equivalent of the Royal Society committee. His research involves work on diphtheria and Pseudomonas toxins.

"The trickiest questions revolve around restriction of publication," said Collier. Currently, data submitted for publication is not subject to restrictions based on potential misuse, but this is clearly a situation that needs changing, he says. Realistically, only a "minute fraction" of data would ever be open to abuse, he said, but at the other extreme, "almost any information could be abused." Identifying real threats will be a complex task, with each case having to be dealt with individually by experts specific to particular fields, he says.

Collier's greatest fear is that, by restricting publication, legitimate research into potentially threatening agents will also be threatened. In ten years time, he suggests, research could be at the same stage it is now. Nevertheless, he welcomes the move by the Royal Society, adding that his NAS committee will shortly be publishing a related document, probably at the beginning of next year.

British microbiologist David Evans, reader in virology at the University of Glasgow, also welcomes the Royal Society proposal, but adds the caveat that any increase in monitoring for potential bioweapon risks must not be accompanied by mountains of extra paperwork. If it were, he says, researchers would surely be tempted to take short-cuts. Ideally, he suggests, additional regulation could perhaps be woven into existing paperwork. Researchers already have to complete a health-and-safety section on grant proposals, he points out; perhaps a potential-for-misuse section could be added to these forms.

Microbiologists are generally aware of the potential for misuse of their research, says Evans, and this is something that has not changed since September 11, 2001. He acknowledges that his own research, on picornnaviruses, could be subverted. But the question of making official note of such potential has not been raised before, and would be a welcome advance.

"Formally, we don't have to," said Evans. "Formally, I think it would be a good idea if we did."


 
 
Send us your comments for publication.
 
 
Sign up for BioMedNet News weekly email alerts.


 

 





 

See also:
Therapeutic challenges posed by bacterial bioterrorism threats
[Review]
Peter H. Gilligan
Current Opinion in Microbiology, 2002, 5:5:489-495

Bioterrorism: responding to an emerging threat
[Opinion]
Margaret A. Hamburg
Trends in Biotechnology, 2002, 20:7:296-298

Bioterrorism: how well are we protected?
[Letters]  Vadim V. Demidov
Trends in Biotechnology, 2002, 20:5:192

New approaches and old problems in the shadow of bioterrorism
[Meeting report]
John M. Leong, Nikhat Parveen and Jon D. Goguen
Trends in Microbiology, 2002, 10:3:112-114
 




 
Today's News Stories
News Archive


BioMedNet
Home
News &
Comment
My BMN
 
Help System
 
Send Feedback to BMN
 
Information for Advertisers © Elsevier Science Limited 2002

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.